| Pharmaceutical active ingredients: |
| Nalorphine |
| Available forms, composition and doses of Antorfin: |
| N / A |
| Antorfin medical category: |
| Human:AntidotesDetoxifying agents and drugs used in substance dependenceOpioid receptor antagonists |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| V03AB02 - Nalorphine |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Unidentified Pharmaceutical Company |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Anti-VLA4 | Natalizumab | Unidentified Pharmaceutical Company |
| Antodine | Famotidine | Unidentified Pharmaceutical Company |
| Antomin | Diphenhydramine | Unidentified Pharmaceutical Company |
| Antophysin | Gonadotropin | Unidentified Pharmaceutical Company |
| Antora | Pentaerithrityl Tetranitrate | Unidentified Pharmaceutical Company |
| Antorin | Follicle Stimulating Hormone | Unidentified Pharmaceutical Company |
| Antorphin | Nalorphine | Unidentified Pharmaceutical Company |
| Antorphine | Nalorphine | Unidentified Pharmaceutical Company |
| Antostab | Gonadotropin Serum | Unidentified Pharmaceutical Company |
| Antoxol | Dimercaprol | Unidentified Pharmaceutical Company |